FLT3 and acute myeloid leukemia: First, decreased sensitivity to MLN4924 was noted in both stem (HSC and MPP) and progenitor (CMP and MEP) populations isolated from AML patient 1, who had FLT3 ITD+ disease (Fig. 2, open triangles; Table 1).